- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
The Board of Directors of Jubilant Pharmova Limited has approved the unaudited financial results for the quarter and nine months ended December 31, 2024. For the quarter, total revenue from operations stood at ₹1,821.07 Cr, while net profit for the period was ₹100.70 Cr. The consolidated results showed total revenue of ₹1,821.07 Cr and a net profit of ₹100.70 Cr for the same quarter, reflecting a decrease compared to the previous quarter. The company continues to focus on operational efficiencies and strategic initiatives for growth and profitability.